This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.


Competition & State Aid

  • European Court of Auditors reviews risks, challenges and opportunities in the EU's economic policy response to the COVID-19 crisis
  • EU approves new and amended Member State measures to support the economy

Trade / Export Controls

  • No noteworthy developments for this issue

Medicines, Medical Devices, and Personal Protective Equipment

  • European medicines agencies network presents Strategy to 2025
  • EMA further expands transparency in relation to COVID-19 medicinal products
  • EMA commences evaluation for granting marketing authorizations for two COVID-19 vaccines
  • EMA starts rolling review of COVID-19 vaccine

Cybersecurity, Privacy & Data Protection

  • No noteworthy developments for this issue

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.